Mar 5, 2026 11:31AM
Mar 5, 2026 07:02AM
Jan 27, 2026 06:32AM
Dec 19, 2025 06:30AM
Nov 12, 2025 04:47AM
Nov 11, 2025 08:52AM
Nov 7, 2025 08:06AM Altimmune presents AI analysis showing liver fibrosis reduction with pemvidutide
Nov 6, 2025 07:02AM
Oct 20, 2025 06:56AM
Sep 19, 2025 06:50AM
Aug 12, 2025 07:00AM
Aug 11, 2025 07:30AM
Jul 10, 2025 04:14AM
Jul 10, 2025 02:22AM Goldman Sachs Resumes Altimmune (ALT) at Sell
Jul 9, 2025 07:30AM
Jun 27, 2025 10:02AM
Jun 27, 2025 06:52AM
Jun 26, 2025 07:02AM
Jun 5, 2025 04:24AM
Jun 2, 2025 07:07AM
May 19, 2025 07:31AM Altimmune (ALT) Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder
May 14, 2025 07:37AM
May 13, 2025 07:02AM
May 13, 2025 07:01AM
May 12, 2025 07:53AM
Apr 23, 2025 04:15AM
Apr 4, 2025 06:42AM
Apr 2, 2025 04:38AM Citizens JMP Reiterates Market Outperform Rating on Altimmune (ALT)
Mar 16, 2025 04:00AM
Mar 14, 2025 09:05AM
Mar 14, 2025 04:06AM
Mar 4, 2025 06:43AM
Feb 27, 2025 04:59PM
Feb 27, 2025 07:02AM
Feb 6, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Altimmune (ALT)
Jan 7, 2025 04:06PM
Jan 3, 2025 08:23AM
Dec 19, 2024 07:30AM
Nov 15, 2024 11:01AM
Nov 12, 2024 07:02AM
Nov 12, 2024 03:20AM
Nov 11, 2024 07:30AM Altimmune (ALT) Appoints Greg Weaver as CFO
Nov 7, 2024 07:30AM
Sep 30, 2024 07:32AM
Sep 10, 2024 07:46AM
Sep 7, 2024 08:00PM
Sep 3, 2024 07:32AM
Aug 8, 2024 07:01AM
Jul 25, 2024 07:30AM Altimmune (ALT) Announces Publication of Clinical Study of Pemvidutide in Metabolic Dysfunction-Associated Steatotic Liver Disease
Jun 27, 2024 10:28AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All